Li Li

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Body Composition

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Ping-Ping Zhang, You-Xin Wang, Fang-Jing Shen, Yun-Fei Xing, Jia-Ying Gu, Xue-Ying Li, Han Jin, Shi-Feng Jin, Miao Xu, Hai-Jun Wang, Hui Wang, Li Li
Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study). Trials 25 (1) (2024)
Miao Xu, Yi Lin, Naibin Yang, Jialin Li, Li Li, Huiqing Ding, Cheng-Fu Xu
Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation. Revista da Associacao Medica Brasileira (1992) 70 (3) (2024)
Shuqin Chen, Xuepeng Wang, Yong Jin, Xueqin Chen, Qifa Song, Gang Wei, Li Li
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment [Response to Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Miao Xu, Yi Lin, Naibin Yang, Jialin Li, Li Li, Huiqing Ding, Cheng-Fu Xu
Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation. Revista da Associacao Medica Brasileira (1992) 70 (3) (2024)
Miao Xu, Yi Lin, Naibin Yang, Jialin Li, Li Li, Huiqing Ding, Cheng-Fu Xu
Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation. Revista da Associacao Medica Brasileira (1992) 70 (3) (2024)
Ping-Ping Zhang, You-Xin Wang, Fang-Jing Shen, Yun-Fei Xing, Jia-Ying Gu, Xue-Ying Li, Han Jin, Shi-Feng Jin, Miao Xu, Hai-Jun Wang, Hui Wang, Li Li
Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study). Trials 25 (1) (2024)
Wei Du, Shanshan Jiang, Shengxiang Yin, Rongjiang Wang, Chunling Zhang, Bin-Cheng Yin, Jialin Li, Li Li, Nan Qi, Ying Zhou, Bang-Ce Ye
The microbiota-dependent tryptophan metabolite alleviates high-fat diet-induced insulin resistance through the hepatic AhR/TSC2/mTORC1 axis. Proceedings of the National Academy of Sciences of the United States of America 121 (35) (2024)
Ping-Ping Zhang, You-Xin Wang, Fang-Jing Shen, Yun-Fei Xing, Jia-Ying Gu, Xue-Ying Li, Han Jin, Shi-Feng Jin, Miao Xu, Hai-Jun Wang, Hui Wang, Li Li
Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study). Trials 25 (1) (2024)
Shuqin Chen, Xuepeng Wang, Yong Jin, Xueqin Chen, Qifa Song, Gang Wei, Li Li
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Shuqin Chen, Xuepeng Wang, Yong Jin, Xueqin Chen, Qifa Song, Gang Wei, Li Li
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment [Response to Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Shuqin Chen, Xuepeng Wang, Yong Jin, Xueqin Chen, Qifa Song, Gang Wei, Li Li
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Wei Du, Shanshan Jiang, Shengxiang Yin, Rongjiang Wang, Chunling Zhang, Bin-Cheng Yin, Jialin Li, Li Li, Nan Qi, Ying Zhou, Bang-Ce Ye
The microbiota-dependent tryptophan metabolite alleviates high-fat diet-induced insulin resistance through the hepatic AhR/TSC2/mTORC1 axis. Proceedings of the National Academy of Sciences of the United States of America 121 (35) (2024)
Wei Du, Shanshan Jiang, Shengxiang Yin, Rongjiang Wang, Chunling Zhang, Bin-Cheng Yin, Jialin Li, Li Li, Nan Qi, Ying Zhou, Bang-Ce Ye
The microbiota-dependent tryptophan metabolite alleviates high-fat diet-induced insulin resistance through the hepatic AhR/TSC2/mTORC1 axis. Proceedings of the National Academy of Sciences of the United States of America 121 (35) (2024)
Xueyu Li, Kaushik Chattopadhyay, Xiaoting Chen, Jialin Li, Miao Xu, Xueqin Chen, Li Li
Association Between Physical Activity and Arterial Stiffness in Patients with Type 2 Diabetes in Ningbo, China: A Cross-Sectional Study. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Xueyu Li, Kaushik Chattopadhyay, Xingjun Qian, Jingjia Yu, Miao Xu, Li Li, Cheng Chi, Jialin Li
Association Between Sleep Duration and Albuminuria in Patients with Type 2 Diabetes: A Cross-Sectional Study in Ningbo, China. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Miao Xu, Kaushik Chattopadhyay, Xingjun Qian, Jialin Li, Xueyu Li, Cheng Chi, Li Li
Association Between Nocturnal Sleep Duration and Obesity Indicators Among People with Type 2 Diabetes: A Cross-Sectional Study in Ningbo, China. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Yanni Li, Nicholas J Buys, Li Li, Cheng Chi
Sleep Quality and Its Determinants Among Type 2 Diabetes Patients with Comorbid Metabolic Syndrome. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Shuqin Chen, Yong Jin, Miao Xu, Pingping Zhang, Ye Zhou, Xingjun Qian, Qifa Song, Shizhong Bu, Cheng Chi, Li Li
Relationship Between Thyroid Hormone and Liver Steatosis Analysis Parameter in Obese Participants: A Case-Control Study. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Yi Lin, Kaushik Chattopadhyay, Xi Yang, Jia-Lin Li, Yan-Shu Chen, Ye Zhou, Li Li
Association Between Dietary Salt and Plasma Glucose, Insulin and Hemoglobin A 1c Levels Among Type 2 Diabetes Patients in Eastern China. Diabetes, metabolic syndrome and obesity : targets and therapy 14 (2021)
Leanne Chang, Kaushik Chattopadhyay, Jialin Li, Miao Xu, Li Li
Interplay of Support, Comparison, and Surveillance in Social Media Weight Management Interventions: Qualitative Study. JMIR mHealth and uHealth 9 (3) (2021)
Xueyu Li, Kaushik Chattopadhyay, Shengnan Xu, Yanshu Chen, Miao Xu, Li Li, Jialin Li
Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study. BMJ open 11 (1) (2021)
Xi Yang, Yi Lin, Guo-Dong Xu, Yan-Shu Chen, Ye Zhou, Cheng Chi, Li Li
Optimal Cut-Off Values of Visceral Fat Area for Predicting Metabolic Syndrome Among Type 2 Diabetes Patients in Ningbo, China. Diabetes, metabolic syndrome and obesity : targets and therapy 14 (2021)
Angharad Woolley, Li Li, Josie Solomon, Jialin Li, Kai Huang, Punam Chahal, Priya Chahal, Gloria Tu, Pritpal Chahal, Kaushik Chattopadhyay
What are the development priorities for management of type 2 diabetes by general practitioners in Ningbo, China: a qualitative study of patients' and practitioners' perspectives. BMJ open 10 (9) (2020)
Jialin Li, Kaushik Chattopadhyay, Miao Xu, Yanshu Chen, Fangfang Hu, Jianping Chu, Li Li
Prevalence and associated factors of vascular complications among inpatients with type 2 diabetes: A retrospective database study at a tertiary care department, Ningbo, China. PloS one 15 (6) (2020)
Li Li, Qifa Song, Xi Yang
Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults. Journal of diabetes research 2019 (2019)
Jialin Li, Kaushik Chattopadhyay, Miao Xu, Yanshu Chen, Fangfang Hu, Xingzhen Wang, Li Li
Prevalence and predictors of polypharmacy prescription among type 2 diabetes patients at a tertiary care department in Ningbo, China: A retrospective database study. PloS one 14 (7) (2019)
Jialin Li, Kaushik Chattopadhyay, Miao Xu, Yanshu Chen, Fangfang Hu, Jianping Chu, Li Li
Glycaemic control in type 2 diabetes patients and its predictors: a retrospective database study at a tertiary care diabetes centre in Ningbo, China. BMJ open 8 (3) (2018)